Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 214

1.

Preclinical models for precision oncology.

Ibarrola-Villava M, Cervantes A, Bardelli A.

Biochim Biophys Acta. 2018 Jun 28. pii: S0304-419X(18)30066-0. doi: 10.1016/j.bbcan.2018.06.004. [Epub ahead of print] Review.

PMID:
29959990
2.

Next generation immune-checkpoints for cancer therapy.

Donini C, D'Ambrosio L, Grignani G, Aglietta M, Sangiolo D.

J Thorac Dis. 2018 May;10(Suppl 13):S1581-S1601. doi: 10.21037/jtd.2018.02.79. Review.

3.

Consensus guidelines for the use and interpretation of angiogenesis assays.

Nowak-Sliwinska P, Alitalo K, Allen E, Anisimov A, Aplin AC, Auerbach R, Augustin HG, Bates DO, van Beijnum JR, Bender RHF, Bergers G, Bikfalvi A, Bischoff J, Böck BC, Brooks PC, Bussolino F, Cakir B, Carmeliet P, Castranova D, Cimpean AM, Cleaver O, Coukos G, Davis GE, De Palma M, Dimberg A, Dings RPM, Djonov V, Dudley AC, Dufton NP, Fendt SM, Ferrara N, Fruttiger M, Fukumura D, Ghesquière B, Gong Y, Griffin RJ, Harris AL, Hughes CCW, Hultgren NW, Iruela-Arispe ML, Irving M, Jain RK, Kalluri R, Kalucka J, Kerbel RS, Kitajewski J, Klaassen I, Kleinmann HK, Koolwijk P, Kuczynski E, Kwak BR, Marien K, Melero-Martin JM, Munn LL, Nicosia RF, Noel A, Nurro J, Olsson AK, Petrova TV, Pietras K, Pili R, Pollard JW, Post MJ, Quax PHA, Rabinovich GA, Raica M, Randi AM, Ribatti D, Ruegg C, Schlingemann RO, Schulte-Merker S, Smith LEH, Song JW, Stacker SA, Stalin J, Stratman AN, Van de Velde M, van Hinsbergh VWM, Vermeulen PB, Waltenberger J, Weinstein BM, Xin H, Yetkin-Arik B, Yla-Herttuala S, Yoder MC, Griffioen AW.

Angiogenesis. 2018 May 15. doi: 10.1007/s10456-018-9613-x. [Epub ahead of print] Review.

4.

Known and novel roles of the MET oncogene in cancer: a coherent approach to targeted therapy.

Comoglio PM, Trusolino L, Boccaccio C.

Nat Rev Cancer. 2018 Jun;18(6):341-358. doi: 10.1038/s41568-018-0002-y. Review.

PMID:
29674709
5.

Tumor progression: the neuronal input.

Arese M, Bussolino F, Pergolizzi M, Bizzozero L, Pascal D.

Ann Transl Med. 2018 Mar;6(5):89. doi: 10.21037/atm.2018.01.01. Review.

6.

Fluoropyrimidine-induced cardiotoxicity.

Depetris I, Marino D, Bonzano A, Cagnazzo C, Filippi R, Aglietta M, Leone F.

Crit Rev Oncol Hematol. 2018 Apr;124:1-10. doi: 10.1016/j.critrevonc.2018.02.002. Epub 2018 Feb 7. Review.

PMID:
29548480
7.

Taming the Notch Transcriptional Regulator for Cancer Therapy.

Tamagnone L, Zacchigna S, Rehman M.

Molecules. 2018 Feb 15;23(2). pii: E431. doi: 10.3390/molecules23020431. Review.

8.

Therapy for Cancer: Strategy of Combining Anti-Angiogenic and Target Therapies.

Comunanza V, Bussolino F.

Front Cell Dev Biol. 2017 Dec 7;5:101. doi: 10.3389/fcell.2017.00101. eCollection 2017. Review.

9.

Checkpoint inhibitors in endometrial cancer: preclinical rationale and clinical activity.

Mittica G, Ghisoni E, Giannone G, Aglietta M, Genta S, Valabrega G.

Oncotarget. 2017 Aug 8;8(52):90532-90544. doi: 10.18632/oncotarget.20042. eCollection 2017 Oct 27. Review.

10.

Emerging functions of the EGFR in cancer.

Sigismund S, Avanzato D, Lanzetti L.

Mol Oncol. 2018 Jan;12(1):3-20. doi: 10.1002/1878-0261.12155. Epub 2017 Nov 27. Review.

11.

MET Activation and Physical Dynamics of the Metastatic Process: The Paradigm of Cancers of Unknown Primary Origin.

Stella GM, Benvenuti S, Gentile A, Comoglio PM.

EBioMedicine. 2017 Oct;24:34-42. doi: 10.1016/j.ebiom.2017.09.025. Epub 2017 Sep 21. Review.

12.

Olaratumab: PDGFR-α inhibition as a novel tool in the treatment of advanced soft tissue sarcomas.

Vincenzi B, Badalamenti G, Napolitano A, Spalato Ceruso M, Pantano F, Grignani G, Russo A, Santini D, Aglietta M, Tonini G.

Crit Rev Oncol Hematol. 2017 Oct;118:1-6. doi: 10.1016/j.critrevonc.2017.06.006. Epub 2017 Jul 15. Review.

PMID:
28917265
13.

Targeted therapies for gastric cancer: failures and hopes from clinical trials.

Apicella M, Corso S, Giordano S.

Oncotarget. 2017 Jan 26;8(34):57654-57669. doi: 10.18632/oncotarget.14825. eCollection 2017 Aug 22. Review.

14.

Tumor Evolution as a Therapeutic Target.

Amirouchene-Angelozzi N, Swanton C, Bardelli A.

Cancer Discov. 2017 Jul 20. doi: 10.1158/2159-8290.CD-17-0343. [Epub ahead of print] Review.

15.

Treating breast cancer with cell-based approaches: an overview.

Gallo S, Sangiolo D, Carnevale Schianca F, Aglietta M, Montemurro F.

Expert Opin Biol Ther. 2017 Oct;17(10):1255-1264. doi: 10.1080/14712598.2017.1356816. Epub 2017 Jul 20. Review.

PMID:
28728493
16.

Second-line chemotherapy for advanced pancreatic cancer: Which is the best option?

Aprile G, Negri FV, Giuliani F, De Carlo E, Melisi D, Simionato F, Silvestris N, Brunetti O, Leone F, Marino D, Santini D, Dell'Aquila E, Zeppola T, Puzzoni M, Scartozzi M.

Crit Rev Oncol Hematol. 2017 Jul;115:1-12. doi: 10.1016/j.critrevonc.2017.03.025. Epub 2017 Apr 20. Review.

PMID:
28602164
17.

MicroRNA-mediated regulatory circuits: outlook and perspectives.

Cora' D, Re A, Caselle M, Bussolino F.

Phys Biol. 2017 Jun 6;14(4):045001. doi: 10.1088/1478-3975/aa6f21. Review.

PMID:
28586314
18.

PDK1: At the crossroad of cancer signaling pathways.

Gagliardi PA, Puliafito A, Primo L.

Semin Cancer Biol. 2018 Feb;48:27-35. doi: 10.1016/j.semcancer.2017.04.014. Epub 2017 May 1. Review.

PMID:
28473254
19.

1st Evidence-based Italian consensus conference on cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinosis from ovarian cancer.

Cavaliere D, Cirocchi R, Coccolini F, Fagotti A, Fambrini M, Federici O, Lorusso D, Vaira M, Ceresoli M, Delrio P, Garofalo A, Pignata S, Scollo P, Trojano V, Amadori A, Ansaloni L, Cariti G, De Cian F, De Iaco P, De Simone M, Deraco M, Donini A, Fiorentini G, Frigerio L, Greggi S, Macrì A, Pasqual EM, Roviello F, Sammartino P, Sassaroli C, Scambia G, Staudacher C, Vici P, Vizza E, Valle M; Italian Society of Surgical Oncology (SICO); Italian Society of Obstetrics and Gynaecology (SIGO); Italian Association of Hospital Obstetricians and Gynaecologists (AOGOI); Italian Association of Medical Oncology (AIOM).

Tumori. 2017 Nov 23;103(6):525-536. doi: 10.5301/tj.5000623. Epub 2017 Apr 20.

PMID:
28430350
20.

Mitochondrial DNA variants in colorectal carcinogenesis: Drivers or passengers?

Errichiello E, Venesio T.

J Cancer Res Clin Oncol. 2017 Oct;143(10):1905-1914. doi: 10.1007/s00432-017-2418-2. Epub 2017 Apr 9. Review. Erratum in: J Cancer Res Clin Oncol. 2018 May 2;:.

PMID:
28393270

Supplemental Content

Loading ...
Support Center